Patents by Inventor Karl Lang

Karl Lang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250122244
    Abstract: The invention relates to methods of treating or preventing a tumor.
    Type: Application
    Filed: October 25, 2024
    Publication date: April 17, 2025
    Applicant: ABALOS THERAPEUTICS GMBH
    Inventors: Karl LANG, Cornelia HARDT, Michael BERGERHAUSEN, Hilal BHAT
  • Patent number: 12129281
    Abstract: The invention relates to a mutant of an arenavirus having improved antitumoral properties. The invention also relates to a method of generating such an arenavirus mutant, related pharmaceutical compositions, medical uses, methods of treatment, and isolated proteins and nucleic acids.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: October 29, 2024
    Assignee: ABALOS THERAPEUTICS GMBH
    Inventors: Karl Lang, Cornelia Hardt, Michael Bergerhausen, Hilal Bhat
  • Publication number: 20220033445
    Abstract: The invention relates to a mutant of an arenavirus having improved antitumoral properties. The invention also relates to a method of generating such an arenavirus mutant, related pharmaceutical compositions, medical uses, methods of treatment, and isolated proteins and nucleic acids.
    Type: Application
    Filed: September 12, 2019
    Publication date: February 3, 2022
    Applicant: ABALOS THERAPEUTICS GMBH
    Inventors: Karl LANG, Cornelia HARDT, Michael BERGERHAUSEN, Hilal BHAT
  • Patent number: 10822388
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: November 3, 2020
    Assignee: University Health Network
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Publication number: 20180016320
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Application
    Filed: May 1, 2017
    Publication date: January 18, 2018
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Patent number: 9670265
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: June 6, 2017
    Assignee: University Health Network
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Patent number: 9624289
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: April 18, 2017
    Assignee: University Health Network
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Patent number: 9321824
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: April 26, 2016
    Assignee: Universal Health Network
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Patent number: 9228006
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: January 5, 2016
    Assignee: University Health Network
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Publication number: 20150299292
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Application
    Filed: November 12, 2014
    Publication date: October 22, 2015
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Publication number: 20150197551
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Application
    Filed: November 12, 2014
    Publication date: July 16, 2015
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Publication number: 20150139995
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 21, 2015
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Publication number: 20130281356
    Abstract: The present invention is further directed to methods and compositions for modulating the activity of the Toso protein. The invention further encompasses treatment of disorders associated with inflammation, autoimmune disorders, and cancer using compositions that include a soluble Toso protein.
    Type: Application
    Filed: March 14, 2013
    Publication date: October 24, 2013
    Inventors: Michael W. Tusche, Tak W. Mak, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner, Gloria Lin
  • Patent number: 8547580
    Abstract: Print performance is evaluated by printing a diagnostic image comprising color patches. Colorant usage in the printed image is measured by, for instance, scanning each patch. Measured color values are then compared to target color values. Based on the comparison, groups of patches whose color values vary significantly from expectations are identified. Variant groups are then analyzed to identify, in addition to color quality control problems, spatial problems that affect only a localized area of a printed page. Such spatial problems may include, for example, problems with contrast or streaks. A heat map illustrating the differences may be generated to help an operator visualize the spatial problem. A template for the diagnostic image may be selected from a plurality of randomly generated diagnostic targets based on total colorant usage for at least one colorant in each column of color patches. Certain patches may be predefined across for each candidate target.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: October 1, 2013
    Assignee: Apple Inc.
    Inventors: Nancy Wang, Karl Lang
  • Patent number: 8546613
    Abstract: The present invention relates to a compound of formulas I, Ia, Ib and II, wherein R1 to R11 are herein defined.
    Type: Grant
    Filed: February 17, 2009
    Date of Patent: October 1, 2013
    Assignee: Merck Patent GmbH
    Inventors: Thomas Fuchss, Rolf Gericke, Norbert Beier, Florian Lang, Phillipp Lang, Karl Lang
  • Publication number: 20120092701
    Abstract: Print performance is evaluated by printing a diagnostic image comprising color patches. Colorant usage in the printed image is measured by, for instance, scanning each patch. Measured color values are then compared to target color values. Based on the comparison, groups of patches whose color values vary significantly from expectations are identified. Variant groups are then analyzed to identify, in addition to color quality control problems, spatial problems that affect only a localized area of a printed page. Such spatial problems may include, for example, problems with contrast or streaks. A heat map illustrating the differences may be generated to help an operator visualize the spatial problem. A template for the diagnostic image may be selected from a plurality of randomly generated diagnostic targets based on total colorant usage for at least one colorant in each column of color patches. Certain patches may be predefined across for each candidate target.
    Type: Application
    Filed: October 15, 2010
    Publication date: April 19, 2012
    Applicant: Apple Inc.
    Inventors: Nancy Wang, Karl Lang
  • Patent number: D831466
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: October 23, 2018
    Inventors: Karl Lang, Lars Backhaus
  • Patent number: D838028
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: January 8, 2019
    Inventors: Karl Lang, Lars Backhaus
  • Patent number: D853827
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: July 16, 2019
    Inventors: Karl Lang, Lars Backhaus
  • Patent number: D858453
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: September 3, 2019
    Inventors: Karl Lang, Lars Backhaus